503B Compounding for Uncompromised Quality

Safer medications so you can prescribe with confidence.

Epicur Pharma® brings a unique advantage to the veterinary industry. The 503B facility manufactures drugs with consistent potency, sterility, and purity from batch to batch.

A division of Stokes Healthcare and a sister company of Stokes Pharmacy, Epicur® was developed in 2016 to align with the Food and Drug Administration’s (FDA) recommended guidelines and requirements for producing high-quality manufactured drugs. The 503B standards put in place reflect current Good Manufacturing Practices (cGMP), the same regulations in place for human pharmaceuticals.

Epicur Pharma® is proud to be a pioneer in animal drug standards, offering the largest selection of manufactured drugs that are traditionally compounded. Our commitment to drug consistency and quality emphasizes our devotion to patient safety.

Why Epicur®

Our 503B manufactured products have key advantages for veterinarians and patients:

Produced in an FDA Registered Facility under cGMP, the same regulations used by pharmaceutical companies
Tested for Potency and Sterility
Available for hospital and office administration*
Eligible for individual patient scripts through Stokes Pharmacy*

*does not apply to all products

Have questions about compounded control drugs for office use? Our team answered some of the common questions we hear! Read their answers.

Epicur® is proud to partner with and support AAHA in their commitment to continually raising the standard of care for companion animals.

Still have questions about 503B standards? We have answers for you.

The Epicur® Difference

Play Video

Get a glimpse of the quality processes that ensure every batch of your B products gets our A game.

Defining 503B

Play Video

Learn why 503B outsourcing facilities manufacture drugs according to Current Good Manufacturing Processes (cGMP).

Stay stocked on the medications you need most.

Get more details about Epicur’s 503B manufactured products and how they can make a difference in patient outcomes.